Genetic Signatures | GSS - Selling And Administration Expenses

Stock Price
0.12
Daily Change
0 0%
Monthly
-29.41%
Yearly
-76.00%
Q1 Forecast
0.12

Genetic Signatures reported AUD10.52M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.





Selling And Administration Expenses Change Date
Avita Medical AUD 20.98M 253K Jun/2025
Medical Developments International AUD 7.03M 5.91M Jun/2025
Neuren Pharmaceuticals AUD 1.24M 1.09M Jun/2025
Pacific Edge NZD 19.17M 1.32M Dec/2025
Paradigm Biopharmaceuticals AUD 1.61M 747.79K Jun/2025
Starpharma Holdings AUD 1.56M 1.57M Jun/2025
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025